Qube Research & Technologies (QRT)
CELU icon

Qube Research & Technologies (QRT)’s Celularity CELU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-871
Closed -$1.94K – 4375
2023
Q3 		$1.94K Sell
871
-8,057
-90% -$28.9K ﹤0.01% 3575
2023
Q2 		$47.6K Buy
+8,928
New +$57.2K ﹤0.01% 2075
2022
Q2 		– Sell
-2,732
Closed -$238K – 2549
2022
Q1 		$238K Buy
+2,732
New +$164K ﹤0.01% 1883

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CELU Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Celularity (CELU) in Q4 2023, closing a stake of 871 shares — an estimated $1.94K sold.

Qube Research & Technologies (QRT) first reported a position in CELU in Q1 2022 and held it in 3 quarters. The position peaked at $238K in Q1 2022. 37 funds tracked by Wall St. Rank hold CELU as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Celularity position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 871 Celularity shares in Q4 2023, an estimated $1.94K.
  • Qube Research & Technologies (QRT) first reported a position in Celularity in Q1 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Celularity position peaked at $238K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Celularity as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.